Caspase 3 promotes surviving melanoma tumor cell growth after cytotoxic therapy

Journal of Investigative Dermatology

Volumn 134, Issue 6, 2014, Pages 1686-1692

  Donato, Anne L ^a,b   Huang, Qian ^a,c   Liu, Xinjian ^c   Li, Fang ^a   Zimmerman, Mary A ^a   Li, Chuan Yuan ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CYTOTOXIC AGENT; INDOMETACIN; PROSTAGLANDIN E2; VEMURAFENIB; CASPASE 3 INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER RECURRENCE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; IN VITRO STUDY; IN VIVO STUDY; MALE; MELANOMA; MELANOMA CELL; MOUSE; NONHUMAN; PARACRINE SIGNALING; PROTEIN FUNCTION; RECURRENT DISEASE; SKIN CARCINOGENESIS; CELL CULTURE; CELL DEATH; CELL GROWTH; CELL SURVIVAL; DRUG CYTOTOXICITY; ENZYME ACTIVATION; GENE SILENCING; PRIORITY JOURNAL; RADIATION DOSE; SIMULATION; TREATMENT DURATION; TUMOR CELL CULTURE; TUMOR GROWTH; TUMOR RECURRENCE;

ANIMALS; APOPTOSIS; CASPASE 3; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; DINOPROSTONE; ENZYME ACTIVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMANS; LUCIFERASES; MALE; MELANOMA; MICE; MICE, NUDE; MICROSCOPY, FLUORESCENCE; NEOPLASM TRANSPLANTATION; RECURRENCE; SKIN NEOPLASMS;

EID: 84900847833     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2014.18     Document Type: Article

References (28)

1. Akiba S, Sato T (2004) Cellular function of calcium-independent phospholipase A2. Biol Pharm Bull 27:1174-8
2. Balch CM, Gershenwald JE, Soong SJ et al. (2009) Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 27:6199-206
3. Baskin-Bey ES, Washburn K, Feng S et al. (2007) Clinical trial of the pancaspase inhibitor, IDN-6556, in human liver preservation injury. Am J Transplant 7:218-25
4. Castellone MD, Teramoto H, Williams BO et al. (2005) Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis. Science (New York, NY) 310:1504-10
5. Fujita J, Crane AM, Souza MK et al. (2008) Caspase activity mediates the differentiation of embryonic stem cells. Cell Stem Cell 2:595-601
6. Huang Q, Li F, Liu X et al. (2011) Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy. Nat Med 17:860-6
7. Kang TB, Ben-Moshe T, Varfolomeev EE et al. (2004) Caspase-8 serves both apoptotic and nonapoptotic roles. J Immunol 173:2976-84
8. Kennedy NJ, Kataoka T, Tschopp J et al. (1999) Caspase activation is required for T cell proliferation. J Exp Med 190:1891-6
9. Kuida K, Zheng TS, Na S et al. (1996) Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 384:368-72
10. Lakhani SA, Masud A, Kuida K et al. (2006) Caspases 3 and 7: key mediators of mitochondrial events of apoptosis. Science (New York, NY) 311:847-51
11. Li F, He Z, Shen J et al. (2010a) Apoptotic caspases regulate induction of iPSCs from human fibroblasts. Cell Stem Cell 7:508-20
12. Li F, Huang Q, Chen J et al. (2010b) Apoptotic cells activate the phoenix rising pathway to promote wound healing and tissue regeneration. Sci Signal 3:ra13
13. Liu YR, Sun B, Zhao XL et al. (2013) Basal caspase-3 activity promotes migration, invasion, and vasculogenic mimicry formation of melanoma cells. Melanoma Res 23:243-53
14. Makishima T, Hochman L, Armstrong P et al. (2011) Inner ear dysfunction in caspase-3 deficient mice. BMC Neurosci 12:102
15. Martin P, DSouza D, Martin J et al. (2003) Wound healing in the PU.1 null mouse-tissue repair is not dependent on inflammatory cells. Curr Biol 13:1122-8
16. Matikainen T, Perez GI, Zheng TS et al. (2001) Caspase-3 gene knockout defines cell lineage specificity for programmed cell death signaling in the ovary. Endocrinology 142:2468-80
17. Ratziu V, Sheikh MY, Sanyal AJ et al. (2012) A phase 2, randomized, doubleblind, placebo-controlled study of GS-9450 in subjects with nonalcoholic steatohepatitis. Hepatology (Baltimore, MD) 55:419-28
18. Reuter S, Gupta SC, Chaturvedi MM et al. (2010) Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med 49:1603-16
19. Shiffman ML, Pockros P, McHutchison JG et al. (2010) Clinical trial: the efficacy and safety of oral PF-03491390, a pancaspase inhibitor-a randomized placebo-controlled study in patients with chronic hepatitis C. Aliment Pharmacol Ther 31:969-78
20. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62:10-29
21. Singh T, Katiyar SK (2013) Honokiol inhibits non-small cell lung cancer cell migration by targeting PGE(2)-mediated activation of beta-catenin signaling. PLoS One 8:e60749
22. Surh I, Rundhaug JE, Pavone A et al. (2012) The EP1 receptor for prostaglandin E2 promotes the development and progression of malignant murine skin tumors. Mol Carcinog 51:553-64
23. Szymczyk KH, Freeman TA, Adams CS et al. (2006) Active caspase-3 is required for osteoclast differentiation. J Cell Physiol 209:836-44
24. Trott KR (1990) Cell repopulation and overall treatment time. Int J Radiat Oncol Biol Phys 19:1071-5
25. Tubiana M (1988) Repopulation in human tumors. A biological background for fractionation in radiotherapy. Acta Oncol 27:83-8
26. Vo BT, Morton D Jr., Komaragiri S et al. (2013) TGF-beta effects on prostate cancer cell migration and invasion are mediated by PGE2 through activation of PI3K/AKT/mTOR pathway. Endocrinology 154: 1768-79
27. Zhao X, Wang D, Zhao Z et al. (2006) Caspase-3-dependent activation of calcium-independent phospholipase A2 enhances cell migration in nonapoptotic ovarian cancer cells. J Biol Chem 281:29357-68
28. Zhao Y, Agarwal VR, Mendelson CR et al. (1996) Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene. Endocrinology 137:5739-42